Wellstat ImmunoTherapeutics, LLC
6Patents
6Active
6Granted
44Portfolio score
Filing activity: May 4, 2012 → May 14, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9228003B2 | Complement factor B analogs and their uses | Emerging Cross-Sectional Technologies | 4 | Active |
| US9533028B2 | Complement factor B analogs and their uses | Emerging Cross-Sectional Technologies | 2 | Active |
| US10415026B2 | Complement factor B analogs and their uses | Emerging Cross-Sectional Technologies | 2 | Active |
| US11274141B2 | Enveloped virus resistant to complement inactivation for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11001822B2 | Complement factor B analogs and their uses | Emerging Cross-Sectional Technologies | 0 | Active |
| US10689637B2 | Complement factor B analogs and their uses | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.